Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGEN-COV Prevention in Household Contacts
NCT04452318Phase 3Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Jul 2020
- Primary completion
- Oct 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of casirivimab, imdevimab in coronavirus disease 2019 (COVID-19), sponsored by Regeneron Pharmaceuticals. Started Jul 2020; status: completed.
02
Drugs
casirivimabimdevimab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04452318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04452318.